v3.26.1
Condensed Balance Sheets - USD ($)
Jun. 30, 2026
Dec. 31, 2025
Current assets    
Cash and cash equivalents $ 947,796
Due from Sponsor 9,154
Prepaid expense 54,829 30,260
Prepaid insurance 70,801
Total Current Assets 1,082,580 30,260
Deferred offering costs 213,407
Prepaid insurance – long-term 40,710
Investments held in Trust Account 304,335,691
TOTAL ASSETS 305,458,981 243,667
Current liabilities    
Accrued expenses 25,674
Accrued offering costs 78,250 37,690
Total Current Liabilities 103,924 268,609
Deferred underwriting fee payable 12,000,000
Total Liabilities 12,103,924 268,609
Commitments and Contingencies (Note 7)
Class A ordinary shares subject to possible redemption, 30,000,000 shares at a redemption value of $10.14 per share as of June 30, 2026 and no shares as of December 31, 2025 304,335,691
Shareholders’ Deficit    
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding as of June 30, 2026 and December 31, 2025
Additional paid-in capital 24,000
Accumulated deficit (10,981,634) (49,942)
Total Shareholders’ Deficit (10,980,634) (24,942)
TOTAL LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ DEFICIT 305,458,981 243,667
Related Party    
Current liabilities    
Promissory note – related party 230,919
Class A Ordinary Shares    
Shareholders’ Deficit    
Ordinary shares, value
Class B Ordinary Shares    
Shareholders’ Deficit    
Ordinary shares, value [1],[2] $ 1,000 $ 1,000
[1] On February 2, 2026, the underwriters exercised their over-allotment option in full as part of the closing of the Initial Public Offering. As such, the 1,000,000 Founder Shares are no longer subject to forfeiture (Note 6).
[2] On January 29, 2026, the Company issued an additional 1,666,667 Class B ordinary shares to the Sponsor in a share capitalization, resulting in a total of 10,000,000 Founder Shares issued and outstanding, including up to 1,000,000 shares subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters. All share and per share amounts have been retroactively restated (Note 6).